Privi Speciality Chemicals gets USFDA certificate for camphor product
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.
Total Income during Q3 FY25 stood at Rs. 527.37 crore as compared to Rs. 528.77 crore in Q3 FY24
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Total Income in Q2 FY25 stood at Rs. 532.18 crore
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
The Gold Medal distinction places the company in the top 5% of all organizations assessed within EcoVadis's rigorous framework globally
Subscribe To Our Newsletter & Stay Updated